Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Pheochromocytoma (CHP-830)

Expanded access is currently available for this treatment.
Verified September 2014 by Children's Hospital of Philadelphia
Sponsor:
Information provided by (Responsible Party):
John Maris, Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01163383
First received: July 13, 2010
Last updated: September 30, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)